LATTANZIO, ROSSANO
 Distribuzione geografica
Continente #
NA - Nord America 2.143
EU - Europa 2.058
AS - Asia 704
OC - Oceania 5
AF - Africa 3
Continente sconosciuto - Info sul continente non disponibili 3
SA - Sud America 2
Totale 4.918
Nazione #
US - Stati Uniti d'America 2.139
IT - Italia 514
IE - Irlanda 436
CN - Cina 360
SE - Svezia 292
UA - Ucraina 247
TR - Turchia 211
GB - Regno Unito 180
FR - Francia 157
DE - Germania 123
IN - India 82
FI - Finlandia 46
VN - Vietnam 34
AT - Austria 21
BE - Belgio 16
PL - Polonia 7
HK - Hong Kong 6
AU - Australia 4
CA - Canada 4
CZ - Repubblica Ceca 4
JP - Giappone 4
CH - Svizzera 3
NL - Olanda 3
TH - Thailandia 3
BR - Brasile 2
EE - Estonia 2
EG - Egitto 2
EU - Europa 2
GR - Grecia 2
RO - Romania 2
SG - Singapore 2
A2 - ???statistics.table.value.countryCode.A2??? 1
BG - Bulgaria 1
IR - Iran 1
MY - Malesia 1
NZ - Nuova Zelanda 1
PT - Portogallo 1
RU - Federazione Russa 1
SC - Seychelles 1
Totale 4.918
Città #
Chandler 509
Dublin 427
Jacksonville 333
Princeton 163
Ashburn 143
Southend 130
Dearborn 114
Izmir 107
Nanjing 98
Chieti 97
Beijing 79
Ann Arbor 78
Altamura 74
Wilmington 74
Cambridge 51
New York 40
Collecorvino 37
Dong Ket 34
Nanchang 31
Boardman 26
Shenyang 26
Washington 26
Woodbridge 26
Hebei 21
Vienna 21
Jiaxing 17
Pescara 16
Tianjin 16
San Vito Chietino 15
Brussels 14
Houston 14
Milan 14
Los Angeles 13
Grevenbroich 12
Jinan 11
Rome 11
Catania 10
Kunming 10
London 10
Seattle 10
Norwalk 8
Grafing 7
Kraków 7
Carrara 6
Hong Kong 6
Ningbo 6
Oklahoma City 6
Orange 6
Oxford 6
Bologna 5
Edinburgh 5
Hangzhou 5
Helsinki 5
Pune 5
Ancona 4
Carini 4
Changsha 4
Chicago 4
Horley 4
Loma Linda 4
Mcallen 4
Ponte San Pietro 4
Taizhou 4
Basciano 3
Città Sant'Angelo 3
Fremont 3
Hefei 3
Issy-les-moulineaux 3
Kocaeli 3
Lanzhou 3
Messina 3
Montesilvano 3
Nonthaburi 3
Orsogna 3
Parma 3
Perth 3
Shanghai 3
Spoltore 3
Zhengzhou 3
Zurich 3
Atessa 2
Auburn Hills 2
Cattolica 2
Changchun 2
Civitanova Marche 2
Clearwater 2
Fairfield 2
Falls Church 2
Frankfurt (Oder) 2
Frankfurt am Main 2
Gavirate 2
Giulianova 2
Guangzhou 2
Leawood 2
Mountain View 2
Napoli 2
Oakland 2
Ortona 2
Ottawa 2
Ougree 2
Totale 3.168
Nome #
Pyruvate prevents the development of age-dependent cognitive deficits in a mouse model of Alzheimer's disease without reducing amyloid and tau pathology 159
A bicistronic CYCLIN D1-TROP2 mRNA chimera demonstrates a novel oncogenic mechanism in human cancer 151
High methylation levels of PCDH10 predict poor prognosis in patients with pancreatic ductal adenocarcinoma 124
miR-205-5p-mediated downregulation of ErbB/HER receptors in breast cancer stem cells results in targeted therapy resistance 112
Trop-1 Are Conserved Growth Stimulatory Molecules That Mark Early Stages of Tumor Progression 107
Trop-2 activates a dormant Na/K-ATPase/PKCa/CD9/ezrin signaling axis to override the basal growth program of cancer cells 106
Trop-2 is a determinant of breast cancer survival. 106
A unique four-hub protein cluster associates to glioblastoma progression 99
P53 mutations in colorectal cancer from northern Iran: Relationships with site of tumor origin, microsatellite instability and K-ras mutations 97
Sporadic childhood hepatoblastomas show activation of beta-catenin, mismatch repair defects and p53 mutations 94
High expression of 90K (Mac-2 BP) is associated with poor survival in node-negative breast cancer patients not receiving adjuvant systemic therapies 91
An immunohistochemically positive E-cadherin status is not always predictive for a good prognosis in human breast cancer. 90
Overexpression of PY1289-HER3 in sporadic pulmonary carcinoid from patients bearing MEN1 gene variants 89
Trop-2 induces tumor growth through Akt and determines sensitivity to Akt inhibitors 88
Secreted Gal-3BP is a novel promising target for non-internalizing Antibody–Drug Conjugates 88
Functional and prognostic significance of the genomic amplification of frizzled 6 (FZD6) in breast cancer 88
Effects of dietary supplementation of carnosine on mitochondrial dysfunction, amyloid pathology, and cognitive deficits in 3xTg-AD mice 87
The insulin receptor substrate 1 (IRS1) in intestinal epithelial differentiation and in colorectal cancer. 86
Molecular studies of pulmonary carcinoids 84
Inhibition of tumor growth and angiogenesis by SP-2, an anti-lectin, galactoside-binding soluble 3 binding protein (LGALS3BP) antibody. 82
Trop-1 are conserved growth stimulatory molecules that mark early stages of tumor progression 82
Sunitinib malate (SU-11248) alone or in combination with low-dose docetaxel inhibits the growth of DU-145 prostate cancer xenografts. 81
Prognostic relevance of LGALS3BP in human colorectal carcinoma 80
Dual targeting of ErbB-2/ErbB-3 results in enhanced antitumor activity in preclinical models of pancreatic cancer. 77
p53, cathepsin D, Bcl-2 are joint prognostic indicators of breast cancer metastatic spreading 77
Class II phosphoinositide 3-kinase C2β regulates a novel signaling pathway involved in breast cancer progression 76
Vav1 down-modulates Akt in different breast cancer subtypes: a new promising chance to improve breast cancer outcome 75
Dietary zinc supplementation of 3xTg-AD mice increases BDNF levels and prevents cognitive deficits as well as mitochondrial dysfunction 74
The Trop-2 signalling network in cancer growth 74
Combined effect of anti-BAG3 and anti-PD-1 treatment on macrophage infiltrate, CD8(+) T cell number and tumour growth in pancreatic cancer 74
Upregulation of Trop-2 quantitatively stimulates human cancer growth 73
The splicing factor PTBP1 promotes expression of oncogenic splice variants and predicts poor prognosis in patients with non-muscle-invasive bladder cancer 73
PLC-gamma-1 phosphorylation status is prognostic of metastatic risk in patients with early-stage Luminal-A and -B breast cancer subtypes 73
NSC, SC and pleural screening of lung carcinoids for somatic mutations of MEN1 gene. 72
Exosomes as pleiotropic players in pancreatic cancer 72
Pioneers in Pathology 71
Molecular expression profiling shows pseudohypoxia phenotype, vasculogenesis and mitochondrial dysfunction in head and neck paragangliomas 71
Changes of topoisomerase IIalpha expression in breast tumors after neoadjuvant chemotherapy predicts relapse-free survival 68
The role of phospholipase Cγ1 in breast cancer and its clinical significance 68
HER-2/neu mediates oncogenic transformation via altered CREB expression and function. 67
Alterations of MEN1 and E-cadherin/β-catenin complex in sporadic pulmonary carcinoids 65
ABCC3 is a novel target for the treatment of pancreatic cancer 65
Anomalous Fusion of Right Pulmonary Artery to Aortic Arch: Case Report of a Rare and Fatal Congenital Malformation in a Newborn and a Literature Review 64
Methylation analysis of protocadherin genes in pancreatic adenocarcinoma 63
GPR55 signalling promotes proliferation of pancreatic cancer cells and tumour growth in mice, and its inhibition increases effects of gemcitabine 63
Inhibition of tumor growth and angiogenesis by SP-2, an anti-LGALS3BP antibody 62
Intestinal tumour chemoprevention with the antioxidant lipoic acid stimulates the growth of breast cancer. 61
Phospholipase Cgamma1 is required for metastasis development and progression 61
Exenatide Reverts the High-Fat-Diet-Induced Impairment of BDNF Signaling and Inflammatory Response in an Animal Model of Alzheimer's Disease 61
Exenatide promotes cognitive enhancement and positive brain metabolic changes in PS1-KI mice but has no effects in 3xTg-AD animals 60
LGALS3BP, A TUMOR-ASSOCIATED ANTIGEN, UPREGULATES VEGF IN HUMAN BREAST CANCER: POSSIBLE IMPLICATIONS IN ANGIOGENESIS 60
Molecular expression profiling shows overlapping pseudohypoxia phenotype and mitochondrial dysfunction in head and neck paragangliomas 59
Role of phospholipase C in cell invasion and metastasis 58
Antagonist of growth hormone-releasing hormone MIA-690 attenuates the progression and inhibits growth of colorectal cancer in mice 57
Cytoplasmic Trop-1/Ep-CAM overexpression is associated with a favorable outcome in node-positive breast cancer 56
Oxidative Distress Induces Wnt/β-Catenin Pathway Modulation in Colorectal Cancer Cells: Perspectives on APC Retained Functions 55
Preclinical validation of 3-phosphoinositide-dependent protein kinase 1 inhibition in pancreatic cancer 52
[Tissue microarrays] 51
Oxidative Stress Induces WNT Canonical/Non-Canonical Pathway Modulation in Colon Cancer Cells with APC or beta-Catenin Mutation 51
mTrop1/Epcam Knockout Mice Develop Congenital Tufting Enteropathy through Dysregulation of Intestinal E-cadherin/β-catenin 50
Natural compounds, antioxidant, and antiandrogens in the prevention of prostate cancer: in vivo evidences from murine models and human clinical studies. 50
Targeting vesicular lgals3bp by an antibody-drug conjugate as novel therapeutic strategy for neuroblastoma 49
Trop-2, Na+/K+ ATPase, CD9, PKCα, cofilin assemble a membrane signaling super-complex that drives colorectal cancer growth and invasion 47
LGALS3BP, lectin galactoside-binding soluble 3 binding protein, induces vascular endothelial growth factor in human breast cancer cells and promotes angiogenesis. 43
Membranous Nectin-4 expression is a risk factor for distant relapse of T1-T2, N0 luminal-A early breast cancer 42
High nuclear level of Vav1 is a positive prognostic factor in early invasive breast tumors: a role in modulating genes related to the efficiency of metastatic process. 41
Trop-2 induces ADAM10-mediated cleavage of E-cadherin and drives EMT-less metastasis in colon cancer 38
Overexpression of activated phospholipase Cgamma1 is a risk factor for distant metastases in T1-T2, N0 breast cancer patients undergoing adjuvant chemotherapy 37
EV20/NMS-P945, a Novel Thienoindole Based Antibody-Drug Conjugate Targeting HER-3 for Solid Tumors 33
Trop-2 cleavage by ADAM10 is an activator switch for cancer growth and metastasis 31
Cyclin A2 maintains colon homeostasis and is a prognostic factor in CRC 30
USP19 modulates cancer cell migration and invasion and acts as a novel prognostic marker in patients with early breast cancer 26
OXIDATIVE STRESS CAN DIFFERENTIALLY MODULATE WNT/β- CATENIN AND JNK SIGNALLING RELATIONSHIPS IN PRIMARY VERSUS METASTATIC CRC CELLS 21
Thymic Epithelial Tumors as a Model of Networking: Development of a Synergistic Strategy for Clinical and Translational Research Purposes 20
Loss of primary cilia promotes inflammation and carcinogenesis 19
Effects of an ErbB-3 antibody, MP-RM-1, on tumor growth and ligand-dependent and -independent activation of ErbB-3/akt signaling 19
3D-informed targeting of the Trop-2 signal-activation site drives selective cancer vulnerability 19
Extracellular LGALS3BP: a potential disease marker and actionable target for antibody-drug conjugate therapy in glioblastoma 17
The HSP90/R2TP assembly chaperone promotes cell proliferation in the intestinal epithelium 16
Vav1 Down-Modulates Akt2 Expression in Cells from Pancreatic Ductal Adenocarcinoma: Nuclear Vav1 as a Potential Regulator of Akt Related Malignancy in Pancreatic Cancer 15
Protective effects of growth hormone-releasing hormone analogs in DSS-induced colitis in mice 15
The 2EF Antibody Targets a Unique N-Terminal Epitope of Trop-2 and Enhances the In Vivo Activity of the Cancer-Selective 2G10 Antibody 14
The transcriptional terminator XRN2 and the RNA-binding protein Sam68 link alternative polyadenylation to cell cycle progression in prostate cancer 13
Lysosomal lipid switch sensitises to nutrient deprivation and mTOR targeting in pancreatic cancer 13
Human cytomegalovirus infection enhances 5‑lipoxygenase and cycloxygenase‑2 expression in colorectal cancer 12
Pancreatic beta-cell specific BAG3 knockout results in chronic hyperinsulinemia inducing insulin resistance 11
Wingless/It/β-catenin signaling in liver metastasis from colorectal cancer: A focus on biological mechanisms and therapeutic opportunities 10
HER-3 surface expression increases in advanced colorectal cancer representing a potential therapeutic target 9
LGALS3BP is a potential target of antibody-drug conjugates in oral squamous cell carcinoma 9
Soft tissue integration of different abutment surfaces: An experimental study with histological analysis 7
The mitotic checkpoint kinase BUB1 is a direct and actionable target of MYB in adenoid cystic carcinoma 7
Anti-LGALS3BP antibody-drug conjugate treatment induces durable and potent antitumor response in a preclinical model of adenoid cystic carcinoma 6
null 5
Totale 5.424
Categoria #
all - tutte 19.394
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 19.394


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019190 0 0 0 0 0 0 0 0 0 0 35 155
2019/20201.023 278 53 13 23 84 85 141 71 49 116 94 16
2020/2021536 76 8 78 31 64 88 21 12 43 49 11 55
2021/2022516 17 7 25 126 14 48 10 24 31 22 65 127
2022/20231.365 105 241 79 139 139 223 69 125 142 17 42 44
2023/2024804 53 28 67 38 53 289 177 42 25 31 1 0
Totale 5.424